{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:32:53Z","timestamp":1791113573178,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1053\/j.ajkd.2005.03.007","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T09:08:52Z","timestamp":1134464932000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Antagonists of Aldosterone and Proteinuria in Patients With CKD: An Uncontrolled Pilot Study"],"prefix":"10.1053","volume":"46","author":[{"given":"Stefano","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bigazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito M.","family":"Campese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.03.007_bib1","first-page":"S1","article-title":"Excerpts from USRDS 1999 Annual Report","volume":"34","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.03.007_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.RES.37.1.101","article-title":"Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat","volume":"37","author":"Myers","year":"1975","journal-title":"Circ Res"},{"key":"10.1053\/j.ajkd.2005.03.007_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.1996.82","article-title":"Vasoactive hormones and renal sclerosis","volume":"49","author":"Egido","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ki.1997.2","article-title":"Understanding the nature of renal disease progression","volume":"51","author":"Remuzzi","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib5","first-page":"431","article-title":"Role of the renin-angiotensin-aldosterone system in the progression of renal disease","volume":"17","author":"Ibrahim","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.ajkd.2005.03.007_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2005.03.007_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.03.007_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1523-1755.2000.00880.x","article-title":"Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy","volume":"57","author":"Andersen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.03.007_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.03.007_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2005.03.007_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentration in chronic renal failure","volume":"21","author":"Hene","year":"1982","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ki.1978.114","article-title":"Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure","volume":"14","author":"Berl","year":"1978","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2005.03.007_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2005.03.007_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentration in chronic renal disease","volume":"21","author":"Hene","year":"1982","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0272-6386(12)70183-X","article-title":"Hypertension-related renal injury","volume":"22","author":"Walker","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.03.007_bib18","first-page":"S102","article-title":"Dietary protein and the renin-angiotensin system in chronic renal allograft rejection","volume":"52","author":"Rosenberg","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2005.03.007_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure","volume":"10","author":"McElvie","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2005.03.007_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1464-5491.2004.01194.x","article-title":"The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction","volume":"21","author":"Rachmani","year":"2004","journal-title":"Diabet Med"},{"key":"10.1053\/j.ajkd.2005.03.007_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2005.03.007_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.03.007_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.03.007_bib24","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.03.007_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.03.007_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","article-title":"Aldosterone in the development and progression of renal injury","volume":"66","author":"Hollenberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.03.007_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ki.1992.45","article-title":"Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level","volume":"41","author":"Quan","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.RES.36.2.300","article-title":"Malignant hypertension resulting from deoxycorticosterone acetate and salt excess","volume":"36","author":"Gavras","year":"1975","journal-title":"Circ Res"},{"key":"10.1053\/j.ajkd.2005.03.007_bib30","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.03.007_bib31","first-page":"6A","article-title":"The selective aldosterone blocker eplerenone reduces proteinuria without concomitant hyperkalemia","volume":"14","author":"Epstein","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"suppl N","key":"10.1053\/j.ajkd.2005.03.007_bib32","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1093\/eurheartj\/16.suppl_N.92","article-title":"Aldosterone","volume":"16","author":"Bonvalet","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1053\/j.ajkd.2005.03.007_bib33","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone receptor antagonist in myocardial infarction","volume":"281","author":"Delyani","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.ajkd.2005.03.007_bib34","first-page":"1561","article-title":"Evidence for the presence in the arterial walls of intracellular-molecular mechanism for action of mineralocorticoids","volume":"4","author":"Kornel","year":"1982","journal-title":"Clin Exp Hypertens"},{"key":"10.1053\/j.ajkd.2005.03.007_bib35","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(95)03559-P","article-title":"Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney","volume":"111","author":"Roland","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1053\/j.ajkd.2005.03.007_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Sun","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.ajkd.2005.03.007_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.0.CO;2-6","article-title":"Glucocorticoid- and mineralocorticoid receptors in microglial cells","volume":"20","author":"Tanaka","year":"1997","journal-title":"Glia"},{"key":"10.1053\/j.ajkd.2005.03.007_bib38","first-page":"E482","article-title":"Intracerebroventricular infusion of RU 28318 blocks aldosterone-salt hypertension","volume":"258","author":"G\u00f3mez-S\u00e1nchez","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2005.03.007_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1291\/hypres.17.233","article-title":"Differential effects of angiotensin II and aldosterone on cardiovascular hypertrophy","volume":"17","author":"Katayama","year":"1994","journal-title":"Hypertens Res"},{"key":"10.1053\/j.ajkd.2005.03.007_bib40","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1053\/j.ajkd.2005.03.007_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.20.1.67","article-title":"Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses","volume":"20","author":"Ullian","year":"1992","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2005.03.007_bib42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.03.007_bib43","first-page":"S3","article-title":"Cardiac remodelling by fibrous tissue","volume":"30","author":"Sun","year":"1998","journal-title":"Ann Med"},{"key":"10.1053\/j.ajkd.2005.03.007_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-I","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2005.03.007_bib45","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00032.2002","article-title":"Plasminogen activator inhibitor-1 and the kidney","volume":"283","author":"Eddy","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2005.03.007_bib46","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/01.HYP.35.5.1078","article-title":"Local angiotensin II and transforming growth factor-\u03b2 in renal fibrosis in rats","volume":"35","author":"Sun","year":"2000","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2005.03.007_bib47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure","volume":"10","author":"McElvie","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2005.03.007_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/ajkd.2001.22069","article-title":"Late escape from the antiproteinuric effects of ACE inhibitors in nondiabetic renal disease","volume":"37","author":"Shiigai","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605004348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605004348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:30:15Z","timestamp":1759455015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638605004348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0272638605004348"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.03.007","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonists of Aldosterone and Proteinuria in Patients With CKD: An Uncontrolled Pilot Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}